158 related articles for article (PubMed ID: 17125593)
21. In vivo desflurane preconditioning evokes dynamic alterations of metabolic proteins in the heart--proteomic insights strengthen the link between bioenergetics and cardioprotection.
Dyballa-Rukes N; Schuh C; Vogt H; Toma O; Schlack WS; Weber NC; Metzger S
Cell Physiol Biochem; 2014; 33(4):967-81. PubMed ID: 24714055
[TBL] [Abstract][Full Text] [Related]
22. Potential biomarkers for ischemic heart damage identified in mitochondrial proteins by comparative proteomics.
Kim N; Lee Y; Kim H; Joo H; Youm JB; Park WS; Warda M; Cuong DV; Han J
Proteomics; 2006 Feb; 6(4):1237-49. PubMed ID: 16402359
[TBL] [Abstract][Full Text] [Related]
23. Transgene overexpression of alphaB crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion.
Ray PS; Martin JL; Swanson EA; Otani H; Dillmann WH; Das DK
FASEB J; 2001 Feb; 15(2):393-402. PubMed ID: 11156955
[TBL] [Abstract][Full Text] [Related]
24. Hypercholesterolemia abrogates sevoflurane-induced delayed preconditioning against myocardial infarct in rats by alteration of nitric oxide synthase signaling.
Zhang FJ; Ma LL; Wang WN; Qian LB; Yang MJ; Yu J; Chen G; Yu LN; Yan M
Shock; 2012 May; 37(5):485-91. PubMed ID: 22266969
[TBL] [Abstract][Full Text] [Related]
25. [Effect of Resveratrol Preconditioning on Myocardial Dysfunction after Cardiac Arrest in Rats].
Zhang HH; Cao Y; Zeng Z
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Mar; 47(2):152-8. PubMed ID: 27263285
[TBL] [Abstract][Full Text] [Related]
26. Myocardial protection by protykin, a novel extract of trans-resveratrol and emodin.
Sato M; Maulik G; Bagchi D; Das DK
Free Radic Res; 2000 Feb; 32(2):135-44. PubMed ID: 10653484
[TBL] [Abstract][Full Text] [Related]
27. Does white wine qualify for French paradox? Comparison of the cardioprotective effects of red and white wines and their constituents: resveratrol, tyrosol, and hydroxytyrosol.
Dudley JI; Lekli I; Mukherjee S; Das M; Bertelli AA; Das DK
J Agric Food Chem; 2008 Oct; 56(20):9362-73. PubMed ID: 18821770
[TBL] [Abstract][Full Text] [Related]
28. [Proteomics analysis of myocardium after delayed preconditioning with hydrogen sulfide in rat].
Ran K; Tang ZG; Xiao YY; Chang YT; Xu JM
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Apr; 24(4):211-4. PubMed ID: 22464572
[TBL] [Abstract][Full Text] [Related]
29. Insulin inhibits myocardial ischemia-induced apoptosis and alleviates chronic adverse changes in post-ischemic cardiac structure and function.
Xing W; Yan W; Fu F; Jin Y; Ji L; Liu W; Wang L; Lv A; Duan Y; Zhang J; Zhang H; Gao F
Apoptosis; 2009 Sep; 14(9):1050-60. PubMed ID: 19590963
[TBL] [Abstract][Full Text] [Related]
30. Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat.
Penumathsa SV; Thirunavukkarasu M; Koneru S; Juhasz B; Zhan L; Pant R; Menon VP; Otani H; Maulik N
J Mol Cell Cardiol; 2007 Mar; 42(3):508-16. PubMed ID: 17188708
[TBL] [Abstract][Full Text] [Related]
31. Modulation of microRNA 20b with resveratrol and longevinex is linked with their potent anti-angiogenic action in the ischaemic myocardium and synergestic effects of resveratrol and γ-tocotrienol.
Mukhopadhyay P; Das S; Ahsan MK; Otani H; Das DK
J Cell Mol Med; 2012 Oct; 16(10):2504-17. PubMed ID: 22050707
[TBL] [Abstract][Full Text] [Related]
32. Cardioprotection by the transfer of coronary effluent from ischaemic preconditioned rat hearts: identification of cardioprotective humoral factors.
Maciel L; de Oliveira DF; Verissimo da Costa GC; Bisch PM; Nascimento JHM
Basic Res Cardiol; 2017 Sep; 112(5):52. PubMed ID: 28695353
[TBL] [Abstract][Full Text] [Related]
33. Reduction in infarct size by ischemic preconditioning persists in a chronic rat model of myocardial ischemia-reperfusion injury.
Lott FD; Guo P; Toombs CF
Pharmacology; 1996 Feb; 52(2):113-8. PubMed ID: 8851632
[TBL] [Abstract][Full Text] [Related]
34. Ischemic preconditioning: a potential role for constitutive low molecular weight stress protein translocation and phosphorylation?
Eaton P; Awad WI; Miller JI; Hearse DJ; Shattock MJ
J Mol Cell Cardiol; 2000 Jun; 32(6):961-71. PubMed ID: 10888250
[TBL] [Abstract][Full Text] [Related]
35. Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival.
Kim HS; Cho JE; Hwang KC; Shim YH; Lee JH; Kwak YL
Eur J Pharmacol; 2010 Feb; 628(1-3):132-9. PubMed ID: 19944681
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol-Mediated Expression of KLF15 in the Ischemic Myocardium is Associated with an Improved Cardiac Phenotype.
Rogers RG; Otis JS
Cardiovasc Drugs Ther; 2017 Feb; 31(1):29-38. PubMed ID: 28064408
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1.
Fukuda S; Kaga S; Zhan L; Bagchi D; Das DK; Bertelli A; Maulik N
Cell Biochem Biophys; 2006; 44(1):43-9. PubMed ID: 16456233
[TBL] [Abstract][Full Text] [Related]
38. Preconditioning against infarction in the rat heart does not involve a pertussis toxin sensitive G protein.
Liu Y; Downey JM
Cardiovasc Res; 1993 Apr; 27(4):608-11. PubMed ID: 8324794
[TBL] [Abstract][Full Text] [Related]
39. Role of Akt-dependent pathway in resveratrol-mediated cardioprotection after trauma-hemorrhage.
Tsai YF; Liu FC; Lau YT; Yu HP
J Surg Res; 2012 Jul; 176(1):171-7. PubMed ID: 21764074
[TBL] [Abstract][Full Text] [Related]
40. Investigating the involvement of TRPV
Randhawa PK; Jaggi AS
Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):117-126. PubMed ID: 27752734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
